|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash Flows From Operating Activities: | ||||
| Net income (loss) | ||||
| Income earned on Investments held in Trust Account | ||||
| Derivative asset/liabilities | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | ||||
| Stock based compensation | ||||
| Equity compensation expense | ||||
| Non-cash interest expense | ||||
| Non-cash gain related to adjustment of note payable balance | ||||
| Change in fair value of derivative liabilities | ||||
| Loss on issuance of common stock and warrants | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Other receivable | ||||
| Inventory | ||||
| Prepaid expenses | ||||
| Other assets | ||||
| Accrued formation and offering costs | ||||
| Other current assets | ||||
| Accounts payable and accrued expenses | ||||
| Income taxes payable | ||||
| Excise taxes | ||||
| Due to related party | ||||
| Net Cash Used In Operating Activities | ||||
| Cash Flows From Investing Activities: | ||||
| Cash withdrawn for taxes | ||||
| Cash withdrawn for redemptions of Class Common Stock | ||||
| Cash deposited into Trust Account | ||||
| Purchases of property and equipment | ||||
| Capitalized patent costs | ||||
| Net Cash Used In Investing Activities | ||||
| Cash Flows From Financing Activities: | ||||
| Proceeds from convertible note – Sponsor | ||||
| Advances from Target | ||||
| Payments for redemption of Class A Common Stock | ||||
| Capital contributions from Global Graphene Group | ||||
| Cash received from NUBI Trust | ||||
| Reimbursement of consideration shares related to the Forward Purchase Agreement | ||||
| Reimbursement for Recycled Shares related to Forward Purchase Agreement | ||||
| Reimbursement of Recycled Shares related to Forward Purchase Agreement | ||||
| Transaction expenses in connection with the Merger | ||||
| Inflow from Merger | ||||
| Proceeds from convertible notes | ||||
| Proceeds from short-term notes | ||||
| Repayment of short-term notes | ||||
| Proceeds from issuance of common stock and warrants in connection with Private Placement | ||||
| Proceeds from issuance of common stock from exercise of warrants | ||||
| Issuance costs in connection with Private Placement | ||||
| Repayment of related party payable | ||||
| Cash used to settle fractional shares | ||||
| Net Cash Provided By Financing Activities | ||||
| Net change in cash | ||||
| Cash at beginning of period | ||||
| Cash at end of period | ||||
| Cash paid for income taxes | ||||
| Supplemental disclosure | ||||
| Excise tax on redemption of Class A Common Stock | ||||
| Class A Common Stock Redeemable Current Period Remeasurement Adjustment | ||||
| Reclassification of redeemed Class A ordinary shares | ||||
| Cash paid for interest expense | ||||
| Cash paid for federal income taxes | ||||
| Supplemental disclosure of non-cash financing activities: | ||||
| Issuance of Common Stock upon the closing of the Merger | ||||
| Issuance of Common Stock for Forward Purchase Agreement | ||||
| Issuance of Common Stock upon cashless exercise of warrants | ||||
| Stock subscription receivable, net of discount | ||||
| FPA discount accretion | ||||
| Convertible notes converted to common shares | ||||
| Reclassification of warrant derivative liability to additional paid-in capital upon exercise of Series A warrants | ||||
| Conversion of Series C and Series D warrant derivative liabilities into common stock | ||||
| Reverse stock split — reclassification from common stock to additional paid-in capital | ||||
| Capitalized interest to principal balance of short-term note payable | ||||
| Shares issuable upon settlement of warrants | ||||
Loading...